PMC:7228307 / 854-1323
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
20 | 86-90 | Gene | denotes | FcγR | Gene:2213 |
23 | 335-382 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
24 | 384-394 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
27 | 273-280 | Disease | denotes | cancers | MESH:D009369 |
28 | 282-303 | Disease | denotes | inflammatory diseases | MESH:D007249 |
29 | 316-326 | Disease | denotes | infections | MESH:D007239 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T3 | 282-303 | Disease | denotes | inflammatory diseases | http://purl.obolibrary.org/obo/MONDO_0021166 |
T4 | 316-326 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T5 | 335-382 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 335-368 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 384-388 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 43-46 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T12 | 61-62 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T13 | 86-88 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 295-303 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | diseases |
T7 | 316-326 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infections |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
20 | 86-90 | Gene | denotes | FcγR | Gene:2213 |
23 | 335-382 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
24 | 384-394 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
27 | 273-280 | Disease | denotes | cancers | MESH:D009369 |
28 | 282-303 | Disease | denotes | inflammatory diseases | MESH:D007249 |
29 | 316-326 | Disease | denotes | infections | MESH:D007239 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T2 | 335-382 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | NCBItxid:2697049 |
T3 | 384-394 | Species | denotes | SARS‐CoV‐2 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 15-231 | Sentence | denotes | The use of mAb therapeutics has also revealed a “scaffolding” role for FcγR which, in different contexts, may either underpin the therapeutic mAb action such as immune agonism or trigger catastrophic adverse effects. |
T10 | 232-468 | Sentence | denotes | The still unmet therapeutic need in many cancers, inflammatory diseases or emerging infections such as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) requires increased effort on the development of improved and novel mAbs. |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 282-303 | Disease | denotes | inflammatory diseases | http://purl.obolibrary.org/obo/MONDO_0021166 |
T3 | 316-326 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T4 | 335-382 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 384-394 | Disease | denotes | SARS‐CoV‐2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 15-231 | Sentence | denotes | The use of mAb therapeutics has also revealed a “scaffolding” role for FcγR which, in different contexts, may either underpin the therapeutic mAb action such as immune agonism or trigger catastrophic adverse effects. |
T10 | 232-468 | Sentence | denotes | The still unmet therapeutic need in many cancers, inflammatory diseases or emerging infections such as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) requires increased effort on the development of improved and novel mAbs. |